IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+23.92%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$238M
AUM Growth
+$238M
(+31%)
Cap. Flow
+$39M
Cap. Flow
% of AUM
16.39%
Top 10 Holdings %
Top 10 Hldgs %
44.18%
Holding
82
New
31
Increased
11
Reduced
13
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$18.3M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$7.76M |
| 3 |
AGN
Allergan plc
AGN
|
$7.44M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$6.22M |
| 5 |
ENDP
Endo International plc
ENDP
|
$5.38M |
Top Sells
| 1 |
Biogen
BIIB
|
$13.6M |
| 2 |
Medtronic
MDT
|
$9.03M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.13M |
| 4 |
Viatris
VTRS
|
$5.64M |
| 5 |
Amgen
AMGN
|
$5.58M |
Sector Composition
| 1 | Healthcare | 81.93% |
| 2 | Real Estate | 0.91% |
| 3 | Technology | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLXN
51
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.13M | 0.47% |
50,000
-25,000
| -33% | -$563K |
|
52
Haemonetics
HAE
$2.63B
| $1.12M | 0.47% |
+25,000
| New | +$1.12M |
|
53
Nektar Therapeutics
NKTR
$568M
| $1.1M | 0.46% |
+100,000
| New | +$1.1M |
|
|
DBVT
54
DBV Technologies
DBVT
$264M
| $1.05M | 0.44% |
+45,000
| New | +$1.05M |
|
55
Pacific Biosciences
PACB
$393M
| $876K | 0.37% |
+150,000
| New | +$876K |
|
|
ELGX
56
DELISTED
Endologix Inc
ELGX
| $854K | 0.36% |
50,000
+25,000
| +100% | +$427K |
|
57
OraSure Technologies
OSUR
$242M
| $687K | 0.29% |
105,000
-95,000
| -48% | -$622K |
|
|
TSRO
58
DELISTED
TESARO, Inc.
TSRO
| $574K | 0.24% |
+10,000
| New | +$574K |
|
59
Assertio
ASRT
$80.4M
| $560K | 0.24% |
+25,000
| New | +$560K |
|
|
TLOG
60
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
| $438K | 0.18% |
+100,000
| New | +$438K |
|
61
MEI Pharma
MEIP
$160M
| $269K | 0.11% |
150,000
-100,000
| -40% | -$179K |
|
|
IMMU
62
DELISTED
Immunomedics Inc
IMMU
| $192K | 0.08% |
+50,000
| New | +$192K |
|
63
Alkermes
ALKS
$4.78B
| – | – |
-50,000
| Closed | -$2.93M |
|
|
64
Amgen
AMGN
$155B
| – | – |
-35,000
| Closed | -$5.58M |
|
65
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-75,000
| Closed | -$912K |
|
|
66
Biogen
BIIB
$19.4B
| – | – |
-40,000
| Closed | -$13.6M |
|
|
67
Medtronic
MDT
$119B
| – | – |
-125,000
| Closed | -$9.03M |
|
68
QuidelOrtho
QDEL
$1.95B
| – | – |
-75,000
| Closed | -$2.17M |
|
69
Sanofi
SNY
$121B
| – | – |
-100,000
| Closed | -$4.56M |
|
70
Tenet Healthcare
THC
$16.3B
| – | – |
-75,000
| Closed | -$3.8M |
|
|
71
Viatris
VTRS
$12.3B
| – | – |
-100,000
| Closed | -$5.64M |
|
72
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
73
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – |
0
| – | – |
|
|
CMRX
74
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-75,000
| Closed | -$3.02M |
|
|
RAD
75
DELISTED
Rite Aid Corporation
RAD
| – | – |
-200,000
| Closed | -$1.5M |
|